Skip to main content

Leadership Perspectives

Pictured: Paul McKenzie, CEO and Managing Director, CSL

Perspectives and Expertise from CSL Leaders
Nov 30, 2023
CSL Chief Communications & Brand Officer talks to PRWeek about what work looks like these days – including the morning routine he sticks to even when working in other time zones.
Nov 14, 2023
CSL Behring leaders are helping shape the conversation in Europe about how to give patients access to potentially game-changing treatments.
Nov 7, 2023
Three CSL leaders joined the Alliance for mRNA Medicines on a trip to the nation’s capital to discuss the future of mRNA technologies.
Oct 16, 2023
CSL’s Debbie Drane recently spoke on a panel about how to keep momentum going following a record-setting year for cell and gene therapies.
Apr 3, 2023
With a new CEO, a new subsidiary, a newly approved gene therapy and three R&D centers under construction on three different continents, change is coming fast for CSL Limited.
Nov 3, 2022
CSL Head of R&D and Chief Medical Officer Bill Mezzanotte is interviewed in the Australian Financial Review (Subscription Required)
Aug 19, 2022
CSL is taking action by setting 2030 carbon targets, CSL’s Chief Financial Officer says.
May 2, 2022
CSL is building the foundations for decentralised trials to be a core part of its research and development efforts within this decade, speeding up clinical development and opening up trials to more patients. (Subscription Required)

Leadership Perspectives